Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery

Completed · Phase 2 · Has a placebo group

Conditions studied: Adenocarcinoma of the Prostate, Stage II Prostate Cancer

In brief

This randomized phase II trial studies how well finasteride works in treating patients with stage II prostate cancer who are undergoing surgery. Testosterone can cause the growth of prostate cancer cells. Hormone therapy using finasteride may fight prostate cancer by lowering the amount of testosterone the body makes. Giving finasteride before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed.

Key facts

Study ID

NCT00438464

Run by

National Cancer Institute (NCI)

People needed

204

Starts

2007-02-01

Expected to finish

2012-04-01

Last updated by the study team

2016-03-09

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Cleveland Clinic Foundation — Cleveland, Ohio, United States
• Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
• University of Texas Southwestern Medical Center — Dallas, Texas, United States
• M D Anderson Cancer Center — Houston, Texas, United States
• Audie L Murphy Veterans Affairs Hospital — San Antonio, Texas, United States
• Cancer Therapy and Research Center — San Antonio, Texas, United States
• University Hospital — San Antonio, Texas, United States
• University of Texas Health Science Center at San Antonio — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.